Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue

OBJECTIVE: The mammalian target of rapamycin (mTOR)/p70 S6 kinase 1 (S6K1) pathway is a critical signaling component in the development of obesity-linked insulin resistance and operates a nutrient-sensing negative feedback loop toward the phosphatidylinositol 3-kinase (PI 3-kinase)/Akt pathway. Wher...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Houde, Vanessa P., Brûlé, Sophie, Festuccia, William T., Blanchard, Pierre-Gilles, Bellmann, Kerstin, Deshaies, Yves, Marette, André
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874694/
https://ncbi.nlm.nih.gov/pubmed/20299475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1324
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items